Empirical Asset Management, LLC Harvard Bioscience Inc Transaction History

Empirical Asset Management, LLC

  • $791 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 19, 2022
BUY
$2.33 - $3.92 $23,300 - $39,200
10,000 Added 100.0%
20,000 $51,000
Q2 2022

Jul 18, 2022
BUY
$3.28 - $6.42 $32,800 - $64,200
10,000 New
10,000 $36,000

Others Institutions Holding HBIO

# of Institutions
96
Shares Held
31.5M
Call Options Held
700
Put Options Held
2.1K
View Full List

About HARVARD BIOSCIENCE INC

HBIO Quotes by TradingView
  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $90.4M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Empirical Asset Management, LLC Portfolio

Follow Empirical Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email